Orbimed Advisers Largest Holdings in 4th Quarter: 13F Alert

The following are Orbimed Advisors LLC top 10 holdings by market value as of December 31, according to a filing with the U.S. Securities and Exchange Commission on 02/14/2011.

Company Name                 Ticker      Market Value      Current     Change
                                            (USD $)       Position  In Position
Amgen Inc                    AMGN US      136,064,160    2,478,400     -383,100
Genzyme Corp                 GENZ US      134,126,560    1,883,800      251,200
Gilead Sciences Inc          GILD US      121,088,712    3,341,300       -5,500
Merck & Co. Inc.             MRK US       118,805,860    3,296,500      -10,000
Pfizer Inc                   PFE US       108,859,670    6,217,000   -2,755,000
Bristol-Myers Squibb Co      BMY US       104,754,880    3,956,000     -669,500
Biomarin Pharmaceutical Inc  BMRN US       91,817,835    3,409,500     -238,000
Shire Plc-ADR                SHPGY US      90,894,804    1,255,800      -89,600
Thermo Fisher Scientific Inc TMO US        84,363,104    1,523,900      208,500
Allergan Inc                 AGN US        80,227,161    1,168,300       81,800
 
SOURCE: SEC 13F-HR 
FILER: Orbimed Advisors LLC 
QUARTER ENDED: 12/31/2010 
SEC RECEIVED: 02/14/2011 

To contact the reporter on this story: Chris Cappucci in Princeton at ccappucci1@bloomberg.net.

To contact the editor responsible for this story: Rodney Yap at ryap@bloomberg.net.

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.